{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T08:37:21Z","timestamp":1791189441266,"version":"4.1.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Gastroenterol Hepatol"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1038\/ncpgasthep0680","type":"journal-article","created":{"date-parts":[[2007,1,4]],"date-time":"2007-01-04T20:58:08Z","timestamp":1167944288000},"page":"43-51","source":"Crossref","is-referenced-by-count":68,"title":["Drug Insight: the role of albumin in the management of chronic liver disease"],"prefix":"10.1038","volume":"4","author":[{"given":"Florence","family":"Wong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"issue":"Suppl 5","key":"BFncpgasthep0680_CR1","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1046\/j.1365-2036.16.s5.2.x","volume":"16","author":"TW Evans","year":"2002","unstructured":"Evans TW (2002) Review article: albumin as a drug\u2014biological effects of albumin unrelated to oncotic pressure. Aliment Pharmacol Ther 16 (Suppl 5): 6\u201311","journal-title":"Aliment Pharmacol Ther"},{"key":"BFncpgasthep0680_CR2","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/0006-2952(88)90126-8","volume":"37","author":"B Halliwell","year":"1988","unstructured":"Halliwell B (1988) Albumin, an important extracellular antioxidant. Biochem Pharmacol 37: 569\u2013571","journal-title":"Biochem Pharmacol"},{"key":"BFncpgasthep0680_CR3","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1172\/JCI104594","volume":"41","author":"WL Beeken","year":"1962","unstructured":"Beeken WL et al. (1962) Studies of 131I-albumin catabolism and distribution in normal young male adults. J Clin Invest 41: 1312\u20131333","journal-title":"J Clin Invest"},{"key":"BFncpgasthep0680_CR4","first-page":"153","volume":"45","author":"T Peters Jr","year":"1997","unstructured":"Peters T Jr (1997) Serum albumin. Adv Protein Chem 45: 153\u2013203","journal-title":"Adv Protein Chem"},{"key":"BFncpgasthep0680_CR5","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/S1590-8658(03)00383-9","volume":"35","author":"V Arroyo","year":"2003","unstructured":"Arroyo V and Colmenero J (2003) Use of albumin in the management of patients with decompensated cirrhosis. An independent verdict. Dig Liver Dis 35: 668\u2013672","journal-title":"Dig Liver Dis"},{"key":"BFncpgasthep0680_CR6","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1152\/japplphysiol.01274.2005","volume":"100","author":"MK Nguyen","year":"2006","unstructured":"Nguyen MK and Kurtz I (2006) Quantitative Interrelationship between Gibbs\u2013Donnan equilibrium, osmolality of body fluid compartments, and plasma water sodium concentration. J Appl Physiol 100: 1293\u20131300","journal-title":"J Appl Physiol"},{"key":"BFncpgasthep0680_CR7","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1080\/15216540500404093","volume":"57","author":"M Fasano","year":"2005","unstructured":"Fasano M et al. (2005) The extraordinary ligand binding properties of human serum albumin. IUBMB Life 57: 787\u2013796","journal-title":"IUBMB Life"},{"key":"BFncpgasthep0680_CR8","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jmb.2005.07.075","volume":"353","author":"J Ghuman","year":"2005","unstructured":"Ghuman J et al. (2005) Structural basis of the drug-binding specificity of human serum albumin. J Mol Biol 353: 38\u201352","journal-title":"J Mol Biol"},{"key":"BFncpgasthep0680_CR9","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1172\/JCI117480","volume":"94","author":"JS Scharfstein","year":"1994","unstructured":"Scharfstein JS et al. (1994) In vivo transfer of nitric oxide between a plasma protein-bound reservoir and low molecular weight thiols. J Clin Invest 94: 1432\u20131439","journal-title":"J Clin Invest"},{"key":"BFncpgasthep0680_CR10","first-page":"274","volume":"48","author":"AV Greco","year":"2000","unstructured":"Greco AV et al. (2000) Subclinical hepatic encephalopathy: role of tryptophan binding to albumin and the competition with indole-3-acetic acid. J Investig Med. 48: 274\u2013280","journal-title":"J Investig Med."},{"key":"BFncpgasthep0680_CR11","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/S0014-827X(99)00082-8","volume":"54","author":"F Kouoh","year":"1999","unstructured":"Kouoh F et al. (1999) Antioxidant properties of albumin: effect on oxidative metabolism of human neutrophil granulocytes. Farmaco 54: 695\u2013699","journal-title":"Farmaco"},{"key":"BFncpgasthep0680_CR12","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1097\/01.CCM.0000114574.18641.5D","volume":"32","author":"GJ Quinlan","year":"2004","unstructured":"Quinlan GJ et al. (2004) Albumin influences total plasma antioxidant capacity favorably in patients with acute lung injury. Crit Care Med 32: 755\u2013759","journal-title":"Crit Care Med"},{"key":"BFncpgasthep0680_CR13","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1248\/bpb.25.695","volume":"25","author":"U Kragh-Hansen","year":"2002","unstructured":"Kragh-Hansen U et al. (2002) Practical aspects of the ligand binding and enzymatic properties of human serum albumin. Biol Pharm Bull 25: 695\u2013704","journal-title":"Biol Pharm Bull"},{"key":"BFncpgasthep0680_CR14","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1002\/hep.20720","volume":"42","author":"GJ Quinlan","year":"2005","unstructured":"Quinlan GJ et al. (2005) Albumin: biochemical properties and therapeutic potentials. Hepatology 42: 1211\u20131219","journal-title":"Hepatology"},{"key":"BFncpgasthep0680_CR15","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1097\/00000542-200401000-00012","volume":"100","author":"JD Lang Jr","year":"2004","unstructured":"Lang JD Jr et al. (2004) Albumin and hydroxyethyl starch modulate oxidative inflammatory injury to vascular endothelium. Anesthesiology 100: 51\u201358","journal-title":"Anesthesiology"},{"key":"BFncpgasthep0680_CR16","doi-asserted-by":"publisher","first-page":"H1382","DOI":"10.1152\/ajpheart.1993.264.5.H1382","volume":"264","author":"J Ramirez-Vick","year":"1993","unstructured":"Ramirez-Vick J and Vargas FF (1993) Albumin modulation of paracellular permeability of pig vena caval endothelium shows specificity for pig albumin. Am J Physiol Heart Circ Physiol 264: H1382\u2013H1387","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"BFncpgasthep0680_CR17","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1152\/japplphysiol.00201.2001","volume":"92","author":"MP Margarson","year":"2002","unstructured":"Margarson MP and Soni NC (2002) Effects of albumin supplementation on microvascular permeability in septic patients. J Appl Physiol 92: 2139\u20132145","journal-title":"J Appl Physiol"},{"key":"BFncpgasthep0680_CR18","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1177\/0115426505020003314","volume":"20","author":"CM Mendez","year":"2005","unstructured":"Mendez CM et al. (2005) Albumin therapy in clinical practice. Nutr Clin Pract 20: 314\u2013320","journal-title":"Nutr Clin Pract"},{"key":"BFncpgasthep0680_CR19","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.cacc.2004.01.004","volume":"15","author":"MP Margarson","year":"2004","unstructured":"Margarson MP and Soni NC (2004) Albumin, where are we now? Curr Anaesth Crit Care 15: 61\u201368","journal-title":"Curr Anaesth Crit Care"},{"issue":"7153","key":"BFncpgasthep0680_CR20","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1136\/bmj.317.7153.235","volume":"317","author":"C. I. G. A. Reviewers","year":"1998","unstructured":"Cochrane Injuries Group Albumin Reviewers (1998) Human albumin administration in critically ill patients: systematic review of randomized controlled trials. BMJ 317: 235\u2013240","journal-title":"BMJ"},{"key":"BFncpgasthep0680_CR21","doi-asserted-by":"crossref","unstructured":"The SAFE Study Investigators (2004) A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 350: 2247\u20132256","DOI":"10.1056\/NEJMoa040232"},{"key":"BFncpgasthep0680_CR22","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/S0369-8114(02)00303-6","volume":"50","author":"R Laub","year":"2002","unstructured":"Laub R and Strengers P (2002) Parvoviruses and blood products. Pathol Biol 50: 339\u2013348","journal-title":"Pathol Biol"},{"key":"BFncpgasthep0680_CR23","doi-asserted-by":"publisher","first-page":"149","DOI":"10.7326\/0003-4819-135-3-200108070-00007","volume":"135","author":"MM Wilkes","year":"2001","unstructured":"Wilkes MM and Navickis RJ (2001) Patient survival after human albumin administration: a meta-analysis of randomized controlled trials. Ann Intern Med 135: 149\u2013164","journal-title":"Ann Intern Med"},{"key":"BFncpgasthep0680_CR24","doi-asserted-by":"crossref","first-page":"237","DOI":"10.5694\/j.1326-5377.2004.tb06258.x","volume":"181","author":"SR Finfer","year":"2004","unstructured":"Finfer SR et al. (2004) The SAFE Study: a landmark trial of the safety of albumin in intensive care. Med J Aust 181: 237\u2013238","journal-title":"Med J Aust"},{"key":"BFncpgasthep0680_CR25","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1002\/hep.1840080532","volume":"8","author":"RW Schrier","year":"1988","unstructured":"Schrier RW et al. (1988) Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology 8: 1151\u20131157","journal-title":"Hepatology"},{"key":"BFncpgasthep0680_CR26","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S1590-8658(01)80134-1","volume":"33","author":"M Borzio","year":"2001","unstructured":"Borzio M et al. (2001) Bacterial infection in patients with advanced cirrhosis: a multicentre prospective study. Dig Liver Dis 33: 41\u201348","journal-title":"Dig Liver Dis"},{"key":"BFncpgasthep0680_CR27","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1053\/jhep.2003.50315","volume":"38","author":"KP Moore","year":"2003","unstructured":"Moore KP et al. (2003) The management of ascites\u2013report on the consensus conference of the International Ascites Club. Hepatology 38: 258\u2013266","journal-title":"Hepatology"},{"key":"BFncpgasthep0680_CR28","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/S1590-8658(03)00386-4","volume":"35","author":"AK Burroughs","year":"2003","unstructured":"Burroughs AK (2003) Is the use of albumin of value in cirrhosis? The case not so in favour, or is there an alternative? Dig Liver Dis 35: 664\u2013667","journal-title":"Dig Liver Dis"},{"key":"BFncpgasthep0680_CR29","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/S1590-8658(03)00384-0","volume":"35","author":"G Laffi","year":"2003","unstructured":"Laffi G et al. (2003) Is the use of albumin of value in the treatment of ascites in cirrhosis? The case in favour. Dig Liver Dis 35: 660\u2013663","journal-title":"Dig Liver Dis"},{"key":"BFncpgasthep0680_CR30","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1681\/ASN.V1251010","volume":"12","author":"N Chalasani","year":"2001","unstructured":"Chalasani N et al. (2001) Effects of albumin\/furosemide mixtures on responses to furosemide in hypoalbuminemic patients. J Am Soc Nephrol 12: 1010\u20131016","journal-title":"J Am Soc Nephrol"},{"key":"BFncpgasthep0680_CR31","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1016\/0016-5085(88)90691-9","volume":"94","author":"P Gines","year":"1988","unstructured":"Gines P et al. (1988) Randomized comparative study of therapeutic parcentesis with and without intravenous albumin in cirrhosis. Gastroenterology 94: 1493\u20131502","journal-title":"Gastroenterology"},{"key":"BFncpgasthep0680_CR32","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/S0016-5085(96)70068-9","volume":"111","author":"A Gin\u00e8s","year":"1996","unstructured":"Gin\u00e8s A et al. (1996) Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis. Gastroenterology 111: 1002\u20131010","journal-title":"Gastroenterology"},{"key":"BFncpgasthep0680_CR33","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1097\/00042737-199801000-00002","volume":"10","author":"C Altman","year":"1998","unstructured":"Altman C et al. (1998) Randomized comparative multicenter study of hydroxyethyl starch versus albumin as a plasma expander in cirrhotic patients with tense ascites treated with paracentesis. Eur J Gastroenterol Hepatol 10: 5\u201310","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"BFncpgasthep0680_CR34","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1016\/0016-5085(90)90481-F","volume":"99","author":"R Planas","year":"1990","unstructured":"Planas R et al. (1990) Dextran-70 versus albumin as plasma expanders in cirrhotic patients with ascites treated with total paracentesis. Results of a randomized study. Gastroenterology 99: 1736\u20131744","journal-title":"Gastroenterology"},{"key":"BFncpgasthep0680_CR35","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1002\/hep.1840130416","volume":"13","author":"F Salerno","year":"1991","unstructured":"Salerno F et al. (1991) Randomized comparative study of hemaccel vs albumin infusion after total paracentesis in cirrhotic patients with refractory ascites. Hepatology 13: 707\u2013713","journal-title":"Hepatology"},{"key":"BFncpgasthep0680_CR36","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/0168-8278(92)90176-P","volume":"14","author":"E Fassio","year":"1992","unstructured":"Fassio E et al. (1992) Paracentesis with dextran 70 vs paracentesis with albumin in cirrhosis with tense ascites. Results of a randomized study. J Hepatol 14: 310\u2013316","journal-title":"J Hepatol"},{"key":"BFncpgasthep0680_CR37","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1111\/j.1478-3231.2005.01188.x","volume":"26","author":"R Moreau","year":"2006","unstructured":"Moreau R et al. (2006) Comparison of outcome in patients with cirrhosis and ascites following treatment with albumin or a synthetic colloid. Liver Int 26: 46\u201354","journal-title":"Liver Int"},{"key":"BFncpgasthep0680_CR38","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1665-2681(19)32189-1","volume":"1","author":"D Garcia-Compean","year":"2002","unstructured":"Garcia-Compean D et al. (2002) Treatment of cirrhotic tense ascites with dextran-40 versus albumin associated with large volume paracentesis: a randomized controlled trial. Ann Hepatol 1: 29\u201335","journal-title":"Ann Hepatol"},{"key":"BFncpgasthep0680_CR39","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1053\/jhep.2003.50169","volume":"37","author":"J Sola-Vera","year":"2003","unstructured":"Sola-Vera J et al. (2003) Randomized trial comparing albumin and saline in the prevention of paracentesis-induced circulatory dysfunction in cirrhotic patients with ascites. Hepatology 37: 1147\u20131153","journal-title":"Hepatology"},{"key":"BFncpgasthep0680_CR40","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1136\/gut.50.1.90","volume":"50","author":"R Moreau","year":"2002","unstructured":"Moreau R et al. (2002) Comparison of the effect of terlipressin and albumin on arterial blood volume in patients with cirrhosis and tense ascites treated by paracentesis: a randomised pilot study. Gut 50: 90\u201394","journal-title":"Gut"},{"key":"BFncpgasthep0680_CR41","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1053\/gast.1997.v113.pm9247479","volume":"113","author":"L Ruiz-del-Arbol","year":"1997","unstructured":"Ruiz-del-Arbol L et al. (1997) Paracentesis-induced circulatory dysfunction: mechanism and the effect on hepatic hemodynamics in cirrhosis. Gastroenterology 113: 579\u2013586","journal-title":"Gastroenterology"},{"key":"BFncpgasthep0680_CR42","first-page":"394","volume":"92","author":"K Peltekian","year":"1997","unstructured":"Peltekian K et al. (1997) The effect of large volume paracentesis on total central blood volume, systemic and renal hemodynamics and renal sodium handling in cirrhosis. Am J Gastroenterol 92: 394\u2013399","journal-title":"Am J Gastroenterol"},{"key":"BFncpgasthep0680_CR43","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1001\/archinte.1995.00430040041005","volume":"155","author":"LC Vermeulen Jr","year":"1995","unstructured":"Vermeulen LC Jr et al. (1995) A paradigm for consensus. The University Hospital Consortium guidelines for the use of albumin, nonprotein colloid, and crystalloid solutions. Arch Intern Med 155: 373\u2013379","journal-title":"Arch Intern Med"},{"key":"BFncpgasthep0680_CR44","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1002\/hep.20066","volume":"39","author":"BA Runyon","year":"2004","unstructured":"Runyon BA (2004) Practice Guidelines Committee, American Association for the Study of Liver Diseases (AASLD). Management of adult patients with ascites due to cirrhosis. Hepatology 39: 841\u2013856","journal-title":"Hepatology"},{"key":"BFncpgasthep0680_CR45","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1002\/hep.1840200619","volume":"20","author":"A Follo","year":"1994","unstructured":"Follo A et al. (1994) Renal impairment after spontaneous bacterial peritonitis in cirrhosis: incidence, clinical course, predictive factors and prognosis. Hepatology 20: 1495\u20131501","journal-title":"Hepatology"},{"key":"BFncpgasthep0680_CR46","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1002\/hep.1840020402","volume":"2","author":"JC Hoefs","year":"1982","unstructured":"Hoefs JC et al. (1982) Spontaneous bacterial peritonitis. Hepatology 2: 399\u2013407","journal-title":"Hepatology"},{"key":"BFncpgasthep0680_CR47","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJM199908053410603","volume":"341","author":"P Sort","year":"1999","unstructured":"Sort P et al. (1999) Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med 341: 403\u2013409","journal-title":"N Engl J Med"},{"key":"BFncpgasthep0680_CR48","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1056\/NEJM199912023412317","volume":"341","author":"D Patch","year":"1999","unstructured":"Patch D and Burroughs A (1999) Intravenous albumin in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med 341: 1773\u20131774","journal-title":"N Engl J Med"},{"key":"BFncpgasthep0680_CR49","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/S0016-5085(00)70436-7","volume":"118","author":"A Mogyorosi","year":"2000","unstructured":"Mogyorosi A and Schubert ML (2000) Intravenous albumin reduces mortality in patients with spontaneous bacterial peritonitis. Gastroenterology 118: 231\u2013233","journal-title":"Gastroenterology"},{"key":"BFncpgasthep0680_CR50","doi-asserted-by":"publisher","first-page":"3404","DOI":"10.1111\/j.1572-0241.1999.01662.x","volume":"94","author":"RE Brand","year":"1999","unstructured":"Brand RE (1999) Intravenous albumin in patients with cirrhosis and spontaneous bacterial peritonitis: is it worth the cost? Am J Gastroenterol 94: 3404","journal-title":"Am J Gastroenterol"},{"key":"BFncpgasthep0680_CR51","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1016\/S0140-6736(99)00303-7","volume":"354","author":"BA Runyon","year":"1999","unstructured":"Runyon BA (1999) Albumin infusion for spontaneous bacterial peritonitis. Lancet 354: 1838\u20131839","journal-title":"Lancet"},{"key":"BFncpgasthep0680_CR52","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1002\/hep.20829","volume":"42","author":"J Fern\u00e1ndez","year":"2005","unstructured":"Fern\u00e1ndez J et al. (2005) Randomized unblinded pilot study comparing albumin versus hydroxyethyl starch in spontaneous bacterial peritonitis. Hepatology 42: 627\u2013634","journal-title":"Hepatology"},{"key":"BFncpgasthep0680_CR53","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1002\/hep.20862","volume":"42","author":"F Wong","year":"2005","unstructured":"Wong F (2005) Volume expanders for spontaneous bacterial peritonitis: are we comparing oranges with oranges? Hepatology 42: 533\u2013535","journal-title":"Hepatology"},{"key":"BFncpgasthep0680_CR54","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1016\/S0140-6736(03)14903-3","volume":"362","author":"P Gines","year":"2003","unstructured":"Gines P et al. (2003) Hepatorenal syndrome. Lancet 362: 1819\u20131827","journal-title":"Lancet"},{"key":"BFncpgasthep0680_CR55","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1053\/gast.2002.32364","volume":"122","author":"R Moreau","year":"2002","unstructured":"Moreau R et al. (2002) Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: a retrospective multicenter study. Gastroenterology 122: 923\u2013930","journal-title":"Gastroenterology"},{"key":"BFncpgasthep0680_CR56","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/hep.510270107","volume":"27","author":"M Guevara","year":"1998","unstructured":"Guevara M et al. (1998) Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion. Hepatology 27: 35\u201341","journal-title":"Hepatology"},{"key":"BFncpgasthep0680_CR57","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1053\/jhep.2002.34343","volume":"36","author":"C Duvoux","year":"2002","unstructured":"Duvoux C et al. (2002) Effects of noradrenalin and albumin in patients with type I hepatorenal syndrome: a pilot study. Hepatology 36: 374\u2013380","journal-title":"Hepatology"},{"key":"BFncpgasthep0680_CR58","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/hep.20262","volume":"40","author":"F Wong","year":"2004","unstructured":"Wong F et al. (2004) The use of midodrine, octreotide and transjugular intrahepatic portosystemic stent shunt in the treatment of cirrhotic patients with ascites and renal dysfunction including hepatorenal syndrome. Hepatology 40: 55\u201364","journal-title":"Hepatology"},{"key":"BFncpgasthep0680_CR59","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1053\/jhep.2002.35819","volume":"36","author":"R Ortega","year":"2002","unstructured":"Ortega R et al. (2002) Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, nonrandomized study. Hepatology 36: 941\u2013948","journal-title":"Hepatology"},{"key":"BFncpgasthep0680_CR60","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1136\/gut.31.2.204","volume":"31","author":"PA McCormick","year":"1990","unstructured":"McCormick PA et al. (1990) Intravenous albumin infusion is an effective therapy for hyponatraemia in cirrhotic patients with ascites. Gut 31: 204\u2013207","journal-title":"Gut"},{"key":"BFncpgasthep0680_CR61","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1042\/CS20030357","volume":"106","author":"R Jalan","year":"2004","unstructured":"Jalan R and Kapoor D (2004) Reversal of diuretic-induced hepatic encephalopathy with infusion of albumin but not colloid. Clin Sci 106: 467\u2013474","journal-title":"Clin Sci"},{"issue":"Suppl 3","key":"BFncpgasthep0680_CR62","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1034\/j.1478-3231.23.s.3.1.x","volume":"23","author":"RF Butterworth","year":"2003","unstructured":"Butterworth RF (2003) Role of circulating neurotoxins in the pathogenesis of hepatic encephalopathy: potential for improvement following their removal by liver assist devices. Liver Int 23 (Suppl 3): 5\u20139.","journal-title":"Liver Int"},{"key":"BFncpgasthep0680_CR63","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1002\/hep.1840080207","volume":"8","author":"A Lumsden","year":"1988","unstructured":"Lumsden A et al. (1988) Endotoxin levels measured by a chromogenic assay in portal, hepatic and peripheral venous blood in patients with cirrhosis. Hepatology 8: 232\u2013236","journal-title":"Hepatology"},{"key":"BFncpgasthep0680_CR64","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1002\/hep.1840160421","volume":"16","author":"P Sogni","year":"1992","unstructured":"Sogni P et al. (1992) Evidence for normal nitric oxide-mediated vasodilator tone in conscious rats with cirrhosis. Hepatology 16: 980\u2013983","journal-title":"Hepatology"},{"issue":"Suppl 1","key":"BFncpgasthep0680_CR65","first-page":"286A","volume":"42","author":"J Stange","year":"2005","unstructured":"Stange J et al. (2005) Short-term survival of patients with severe intractable hepatic encephalopathy: the role of albumin dialysis. [Abstract]. Hepatology 42 (Suppl 1): 286A","journal-title":"Hepatology"},{"key":"BFncpgasthep0680_CR66","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1053\/lv.2000.6355","volume":"6","author":"SR Mitzner","year":"2000","unstructured":"Mitzner SR et al. (2000) Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial. Liver Transpl 6: 277\u2013286","journal-title":"Liver Transpl"},{"key":"BFncpgasthep0680_CR67","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1046\/j.1525-1594.2002.06822.x","volume":"26","author":"J Stange","year":"2002","unstructured":"Stange J et al. (2002) The molecular adsorbents recycling system as a liver support system based on albumin dialysis: a summary of preclinical investigations, prospective, randomized, controlled clinical trial, and clinical experience from 19 centers. Artif Organs 26: 103\u2013110","journal-title":"Artif Organs"},{"key":"BFncpgasthep0680_CR68","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1002\/lt.20236","volume":"10","author":"S Sen","year":"2004","unstructured":"Sen S et al. (2004) Pathophysiological effects of albumin dialysis in acute-on-chronic liver failure: a randomized controlled study. Liver Transpl 10: 1109\u20131119","journal-title":"Liver Transpl"},{"key":"BFncpgasthep0680_CR69","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1056\/NEJMe048095","volume":"350","author":"D Cook","year":"2004","unstructured":"Cook D (2004) Is albumin safe? N Engl J Med 350: 2294\u20132296","journal-title":"N Engl J Med"}],"container-title":["Nature Clinical Practice Gastroenterology & Hepatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ncpgasthep0680.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncpgasthep0680","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncpgasthep0680.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T20:04:41Z","timestamp":1684440281000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncpgasthep0680"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":69,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["BFncpgasthep0680"],"URL":"https:\/\/doi.org\/10.1038\/ncpgasthep0680","relation":{},"ISSN":["1743-4378","1743-4386"],"issn-type":[{"value":"1743-4378","type":"print"},{"value":"1743-4386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}